LITSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Lite Strategy, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.16+0.01 (+0.87%)
Close on Oct 19, 2026
- Market cap
- $40.13M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
19.4%
6M of 30M shares
Institutional holders
35
4 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
3 buys · 1 sales
Net sold $803.89K
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LITS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,247,350 | 4.10% | $1.15M | −497,350 | 0.00% |
| Vanguard Capital Management LLC | 1,021,892 | 3.36% | $942.18K | −21,421 | 0.00% |
| RLH Capital LLC | 806,433 | 2.65% | $743.85K | New | 0.36% |
| Two Sigma Investments, LP | 557,011 | 1.83% | $513.79K | −57,431 | 0.00% |
| Geode Capital Management, LLC | 365,019 | 1.20% | $337.09K | −36,072 | 0.00% |
| Citadel Advisors LLC | 357,529 | 1.18% | $329.79K | −372,570 | 0.00% |
| BlackRock, Inc. | 275,829 | 0.91% | $254.43K | +117,938 | 0.00% |
| Marshall Wace, Llp | 232,979 | 0.77% | $214.34K | −100,529 | 0.00% |
| Vanguard Fiduciary Trust Co | 195,392 | 0.64% | $180.15K | +1,397 | 0.00% |
| Jane Street Group, LLC | 192,627 | 0.63% | $177.68K | +135,381 | 0.00% |
| State Street Corp | 115,021 | 0.38% | $106.10K | – | 0.00% |
| UBS Group AG | 91,141 | 0.30% | $84.03K | +39,791 | 0.00% |
| Northern Trust Corp | 75,497 | 0.25% | $69.64K | −4,734 | 0.00% |
| Morgan Stanley | 71,408 | 0.23% | $65.87K | +50 | 0.00% |
| XTX Topco Ltd | 68,165 | 0.22% | $62.88K | −67,859 | 0.00% |
| ADAR1 Capital Management, LLC | 67,292 | 0.22% | $62.07K | – | 0.00% |
| Gsa Capital Partners Llp | 61,850 | 0.20% | $57 | New | 0.00% |
| Nomura Asset Management International Inc. | 29,999 | 0.10% | $28.00K | – | 0.00% |
| Vanguard Global Advisers, LLC | 17,937 | 0.06% | $16.54K | – | 0.00% |
| Susquehanna International Group, Llp | 15,821 | 0.05% | $14.59K | −313 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 35 | 6M | 19.4% | 4 / 5 | 11 / 4 | 1M | 1M |
| Q1 2026 | 36 | 6M | 19.4% | 9 / 3 | 8 / 13 | 2M | 3M |
| Q4 2025 | 41 | 8M | 27.2% | 9 / 11 | 11 / 15 | 3M | 5M |
| Q3 2025 | 47 | 10M | 33.4% | 24 / 12 | 2 / 8 | 9M | 2M |
| Q2 2025 | 31 | 3M | 8.6% | 4 / 5 | 6 / 4 | 0M | 0M |
| Q1 2025 | 31 | 3M | 8.8% | 1 / 6 | 9 / 2 | 0M | 0M |
| Q4 2024 | 32 | 3M | 8.9% | 8 / 4 | 8 / 6 | 0M | 0M |
| Q3 2024 | 30 | 3M | 9.0% | 6 / 6 | 9 / 7 | 0M | 0M |
| Q2 2024 | 32 | 3M | 9.0% | 2 / 7 | 12 / 2 | 0M | 0M |
| Q1 2024 | 32 | 3M | 9.5% | 3 / 8 | 8 / 2 | 0M | 0M |
| Q4 2023 | 31 | 3M | 10.4% | 4 / 10 | 10 / 2 | 1M | 0M |
| Q3 2023 | 29 | 3M | 8.3% | 3 / 9 | 6 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of LITS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 659,936 | 2.17% | $608.72K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 361,956 | 1.19% | $333.87K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 204,707 | 0.67% | $206.75K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 110,588 | 0.36% | $102.01K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 54,468 | 0.18% | $55.01K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 49,681 | 0.16% | $50.18K | 0.00% | May 31, 2026 |
| Nomura Healthcare Fund | 30,000 | 0.10% | $27.67K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 15,724 | 0.05% | $15.88K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 7,350 | 0.02% | $6.78K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 1,900 | 0.01% | $1.75K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Justin J. File | CEO, CFO and Secretary, Director | – | – | Feb 12, 2026 |
| James P. Flynn | Director | 125,000 | 0.41% | Jun 25, 2026 |
| Nicholas Glover | Director | – | – | Nov 19, 2025 |
| Frederick W. Driscoll | Director | 1,875 | 0.01% | Nov 18, 2025 |
| Joshua Riezman | Director | – | – | Nov 18, 2025 |
| Charles Benjamin Lee | Director | 292,397 | 0.96% | Oct 6, 2025 |
| Thomas C. Reynolds | Director | 500 | 0.00% | Jul 17, 2025 |
| Steven D. Wood | Director | 72,092 | 0.24% | Jul 17, 2025 |
| Alexander Schornstein | 10% owner | 3,674,862 | 12.09% | Dec 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James P. Flynn Director | Jun 24, 2026 | Buy | +25,000 | $0.86 | $21.50K | 125,000 |
| James P. Flynn Director | Dec 19, 2025 | Buy | +70,000 | $1.40 | $98.00K | 100,000 |
| Alexander Schornstein 10% owner | Dec 18, 2025 | Sale | −690,611 | $1.37 | $946.14K | 3,674,862 |
| James P. Flynn Director | Nov 19, 2025 | Buy | +12,100 | $1.88 | $22.75K | 30,000 |
| James P. Flynn Director | Sep 30, 2025 | Award | +10,000 | $2.54 | $25.40K | 17,900 |
| Steven D. Wood Director | May 17, 2024 | Award | +3,100 | $3.17 | $9.83K | 4,359 |
| James P. Flynn Director | May 16, 2024 | Award | +7,900 | $3.16 | $24.96K | 7,900 |
| Funicular Funds, LP 10% owner | Oct 20, 2023 | Option exercise | +120,600 | $7.00 | $844.20K | 611,440 |
| Moez Kassam 10% owner | Oct 20, 2023 | Option exercise | +143,200 | $7.00 | $1.00M | 1,057,388 |
| Moez Kassam 10% owner | Oct 20, 2023 | Option exercise | +35,800 | $7.00 | $250.60K | 1,093,188 |
| Funds Management LP Anson 10% owner | Oct 11, 2023 | Option exercise | +10,000 | $7.00 | $70.00K | 914,188 |
| Funds Management LP Anson 10% owner | Oct 11, 2023 | Option exercise | +40,000 | $7.00 | $280.00K | 904,188 |
| Jacob Ma-Weaver 10% owner | Oct 11, 2023 | Option exercise | +30,000 | $7.00 | $210.00K | 490,840 |
| Bruce Ross Winson 10% owner | Sep 22, 2023 | Buy | +48,060 | $6.85 | $329.21K | 864,188 |
| Jacob Ma-Weaver 10% owner | Sep 22, 2023 | Buy | +32,040 | $6.85 | $219.47K | 460,840 |
| Jacob Ma-Weaver 10% owner | Sep 21, 2023 | Buy | +22,400 | $6.46 | $144.70K | 428,800 |
| Moez Kassam 10% owner | Sep 21, 2023 | Buy | +33,600 | $6.46 | $217.06K | 816,128 |
| Jacob Ma-Weaver 10% owner | Sep 20, 2023 | Buy | +80,000 | $6.01 | $480.80K | 406,400 |
| Moez Kassam 10% owner | Sep 20, 2023 | Buy | +120,000 | $6.01 | $721.20K | 782,528 |
| Charles V. Baltic III Director | Feb 28, 2023 | Buy | +81,500 | $0.23 | $18.75K | 105,750 |
| Richard G. Ghalie Chief Medical Officer | Jul 5, 2022 | Tax withholding | −8,196 | $0.54 | $4.43K | 28,927 |
| David M. Urso Chief Operating Officer & GC | Jul 2, 2021 | Tax withholding | −24,825 | $2.94 | $72.99K | 49,281 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 2, 2021 | Tax withholding | −41,320 | $2.94 | $121.48K | 417,312 |
| Daniel P. Gold Phd Chief Executive Officer, Director | May 25, 2021 | Option exercise | +5,000 | $2.52 | $12.60K | 458,632 |
| Frederick W. Driscoll Director | Feb 23, 2021 | Sale | −25,000 | $4.03 | $100.75K | 37,500 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 23, 2020 | Option exercise | +12,000 | $1.57 | $18.84K | 453,632 |
| David M. Urso Chief Operating Officer & GC | Jul 2, 2020 | Award | +50,000 | – | – | 74,106 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 2, 2020 | Award | +80,000 | – | – | 441,632 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Dec 19, 2019 | Buy | +18,750 | $1.60 | $30.00K | 361,632 |
| Thomas C. Reynolds Director | Dec 19, 2019 | Buy | +10,000 | $1.60 | $16.00K | 10,000 |
| Frederick W. Driscoll Director | Dec 19, 2019 | Buy | +62,500 | $1.60 | $100.00K | 62,500 |
| Brian G. Drazba Chief Financial Officer | Dec 19, 2019 | Buy | +12,500 | $1.60 | $20.00K | 37,500 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Sep 27, 2019 | Option exercise | +20,000 | $1.57 | $31.40K | 342,882 |
| Christine Anna White Director | Sep 6, 2019 | Buy | +15,000 | $1.74 | $26.10K | 15,000 |
| David M. Urso Chief Operating Officer & GC | Aug 7, 2018 | Sale | −9,500 | $3.58 | $34.01K | 24,106 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Aug 6, 2018 | Tax withholding | −50,938 | $3.75 | $191.02K | 322,882 |
| Robert D. Mass Chief Medical Officer | Aug 6, 2018 | Tax withholding | −17,709 | $3.75 | $66.41K | 33,661 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Aug 6, 2018 | Tax withholding | −54,093 | $3.75 | $202.85K | 319,727 |
| David M. Urso Chief Operating Officer & GC | Aug 6, 2018 | Tax withholding | −17,764 | $3.75 | $66.62K | 33,606 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Mar 29, 2018 | Tax withholding | −128,920 | $2.07 | $266.86K | 271,080 |
| Charles V. Baltic III Director | Nov 27, 2017 | Sale | −11,000 | $2.21 | $24.31K | 13,250 |
| Charles V. Baltic III Director | Nov 27, 2017 | Buy | +11,000 | $2.25 | $24.75K | 24,250 |
| Vivo Ventures Vii, Llc 10% owner | Nov 9, 2015 | Sale | −157,352 | $1.75 | $275.37K | 3,163,105 |
| Vivo Ventures V, LLC 10% owner | Nov 9, 2015 | Sale | −9,142 | $1.75 | $16.00K | 183,767 |
| Vivo Ventures Vii, Llc 10% owner | Nov 6, 2015 | Sale | −7,560 | $1.85 | $13.99K | 3,320,457 |
| Vivo Ventures V, LLC 10% owner | Nov 6, 2015 | Sale | −440 | $1.85 | $814 | 192,909 |
| Vivo Ventures Vii, Llc 10% owner | Nov 5, 2015 | Sale | −225,660 | $1.91 | $431.01K | 3,328,017 |
| Vivo Ventures V, LLC 10% owner | Nov 5, 2015 | Sale | −13,111 | $1.91 | $25.04K | 193,349 |
| Vivo Ventures Vii, Llc 10% owner | Mar 24, 2015 | Exercise | +455,174 | $3.12 | $1.42M | 3,553,677 |
| Vivo Ventures V, LLC 10% owner | Mar 24, 2015 | Exercise | +26,445 | $3.12 | $82.51K | 206,460 |
| Jeani Delagardelle 10% owner | Mar 24, 2015 | Sale | −1,601,390 | $1.97 | $3.15M | 0 |
| Charles V. Baltic III Director | Jan 21, 2015 | Buy | +5,000 | $3.81 | $19.05K | 24,250 |
| Charles V. Baltic III Director | Dec 31, 2014 | Buy | +1,500 | $4.26 | $6.39K | 5,350 |
| Charles V. Baltic III Director | Dec 31, 2014 | Buy | +1,500 | $4.28 | $6.42K | 19,250 |
| Ronald Hunt 10% owner | Dec 9, 2014 | Sale | −70,081 | $6.01 | $421.19K | 1,601,390 |
| Ronald Hunt 10% owner | Dec 8, 2014 | Sale | −9,004 | $6.05 | $54.47K | 1,671,471 |
| Charles V. Baltic III Director | Jun 30, 2014 | Buy | +950 | $6.60 | $6.27K | 3,850 |
| Charles V. Baltic III Director | Jun 30, 2014 | Buy | +1,050 | $6.52 | $6.85K | 17,750 |
| Jeani Delagardelle 10% owner | Nov 21, 2013 | Sale | −365,000 | $8.25 | $3.01M | 1,680,475 |
| Vivo Ventures V, LLC 10% owner | Oct 29, 2013 | Sale | −44 | $8.27 | $364 | 180,015 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Funds Management LP Anson Former 10% Stockholder | Jul 28, 2025 | 1,093,184 | $7.37M | Jul 28, 2025 | Open Market Purchase(1) |
| Funicular Funds, LP Former member of group that owned 10% | Jul 23, 2025 | 611,440 | $3.79M | Jul 23, 2025 | Open Market Purchase(1) |
| Charles V. Baltic III Director | Jul 22, 2024 | 5,000 | $17.06K | Jul 22, 2024 | Open Market Purchase |